These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3029276)

  • 1. Studies on regional hepatic blood flow and substrate metabolism in patients with hepatocellular carcinoma.
    Liaw KY; Tsang YM; Su CT; Chang CN; Liu JL; Wei TC; Lin JK
    Taiwan Yi Xue Hui Za Zhi; 1986 Dec; 85(12):1151-61. PubMed ID: 3029276
    [No Abstract]   [Full Text] [Related]  

  • 2. The afferent circulation of the liver in patients with primary hepatocellular carcinoma.
    Jakab F; Ráth Z; Schmal F; Nagy P; Faller J
    Hepatogastroenterology; 1995; 42(4):399-402. PubMed ID: 8586376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactose clearance in patients with hepatocellular carcinoma. Evaluation of effective hepatic blood flow.
    Meacci E; Smorlesi C; Chiarantini E; Birardi A; Buzzelli G
    Boll Soc Ital Biol Sper; 1987 Jun; 63(6):489-95. PubMed ID: 2820446
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbohydrate metabolism in patients with primary hepatocellular carcinoma.
    Vinik AI; Pooler W
    Clin Sci Mol Med; 1973 Sep; 45(3):387-96. PubMed ID: 4361808
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
    Sieghart W; Fellner S; Reiberger T; Ulbrich G; Ferlitsch A; Wacheck V; Peck-Radosavljevic M
    Dig Liver Dis; 2009 Dec; 41(12):902-6. PubMed ID: 19501032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatectomy under continuous normothermic interruption of hepatic blood flow in noncirrhotic patients].
    Han M
    Zhonghua Wai Ke Za Zhi; 1992 Jun; 30(6):329-31, 381. PubMed ID: 1337510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deacylation and reacylation of phosphoglyceride in microsomes of Morris hepatoma 7777 and host rat liver.
    Waite M; Parce B; Morton R; Cunningham C; Morris HP
    Cancer Res; 1977 Jul; 37(7 Pt 1):2092-8. PubMed ID: 193634
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on hypoglycaemia in primary carcinoma of the liver. A case report and review of pathogenetic mechanisms.
    Vinik AI; Deppe WM
    S Afr Med J; 1974 Mar; 47(12):518-24. PubMed ID: 4363729
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic perfusion index: a new and useful factor in predicting survival among patients with hepatocellular carcinoma.
    Lin WY; Wang SJ; Kao CH; Hsu CY; Liao SQ; Yeh SH
    Nucl Med Commun; 1993 Oct; 14(10):878-82. PubMed ID: 7694212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vascular elasticity in patients with spontaneous rupture of hepatocellular carcinoma].
    Zhu L; Geng X; Fan S
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):96. PubMed ID: 11983121
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow.
    Nosadini R; Avogaro A; Mollo F; Marescotti C; Tiengo A; Duner E; Merkel C; Gatta A; Zuin R; de Kreutzenberg S
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1125-32. PubMed ID: 6373811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MRA: MR angiography: in hepatocellular carcinoma].
    Fujita N; Nambu T; Kishimoto R
    Nihon Rinsho; 1991 Aug; 49(8):1837-44. PubMed ID: 1664890
    [No Abstract]   [Full Text] [Related]  

  • 13. [Selective exclusion of hepatic outflow and inflow in hepatectomy].
    Qin HD; Li CL; Zhang JG
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):313-5. PubMed ID: 16875637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patomechanisms of hepatic steatosis].
    Fülöp P; Paragh G
    Orv Hetil; 2010 Feb; 151(9):323-9. PubMed ID: 20159747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinomas.
    Taourel P; Dauzat M; Lafortune M; Pradel J; Rossi M; Bruel JM
    Radiology; 1994 Apr; 191(1):189-92. PubMed ID: 8134569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases.
    El-Khoueiry A; Posey JA; Castillo Ferrando JR; Krishnamurthi SS; Syed S; Kollia G; Walters I; Fischer BS; Masson E
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):53-64. PubMed ID: 23719718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Normothermic occlusion of total hepatic blood inflow during hepatectomy. Clinical experience in 81 cases].
    Chen XP
    Zhonghua Wai Ke Za Zhi; 1991 Feb; 29(2):84-6, 141. PubMed ID: 1650683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactose loading tests in patients with hepatocellular carcinoma for the assessment of chemotherapy.
    Buzzelli G; Meacci E; Smorlesi C; Chiarantini E; Birardi A; Gentilini P
    Chemioterapia; 1987 Aug; 6(4):306-9. PubMed ID: 2820595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal hemodynamics in patients with hepatocellular carcinoma.
    Moriyasu F; Ban N; Nishida O; Nakamura T; Soh Y; Miura K; Sakai M; Miyake T; Uchino H
    Radiology; 1986 Dec; 161(3):707-11. PubMed ID: 3024207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors regulating tumor pressure in hepatocellular carcinoma and implications for tumor spread.
    Tanaka T; Yamanaka N; Oriyama T; Furukawa K; Okamoto E
    Hepatology; 1997 Aug; 26(2):283-7. PubMed ID: 9252135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.